MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

MDT

95.62

+0.1%↑

VEEV

286.22

-0.26%↓

A

138.32

+1.29%↑

HQY

93.32

+3.04%↑

PHR.US

22.18

-0.63%↓

Search

Vivani Medical

Fermé

1.33 -0.75

Résumé

Variation du prix de l'action

24h

Actuel

Min

1.33

Max

1.34

Chiffres clés

By Trading Economics

Employés

37

Recommandations

By TipRanks

Recommandations

Achat

Prévisions sur 12 Mois

+191.97% upside

Dividendes

By Dow Jones

Prochains Résultats

12 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

6.4M

70M

Ouverture précédente

2.08

Clôture précédente

1.33

Vivani Medical Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

13 oct. 2025, 21:45 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million -- Update

13 oct. 2025, 21:07 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs to Acquire Industry Ventures for Up to $965 Million

13 oct. 2025, 17:03 UTC

Principaux Mouvements du Marché

Canaan ADRs Climb on Launch of Gas-to-Computing Pilot in Canada

13 oct. 2025, 23:53 UTC

Market Talk

Gold Rises, Buoyed by Bullish Fundamental Backdrop -- Market Talk

13 oct. 2025, 23:39 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Gains -- Market Talk

13 oct. 2025, 22:15 UTC

Market Talk

Global Equities Roundup: Market Talk

13 oct. 2025, 22:15 UTC

Market Talk

Precinct Properties NZ's Equity Raising Looks Opportunistic -- Market Talk

13 oct. 2025, 21:57 UTC

Acquisitions, Fusions, Rachats

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct. 2025, 21:36 UTC

Market Talk

Global Equities Roundup: Market Talk

13 oct. 2025, 21:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

13 oct. 2025, 21:36 UTC

Market Talk

Fletcher's Near-Term Headwinds Don't Cloud Earnings Opportunity -- Market Talk

13 oct. 2025, 21:30 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs to Acquire Industry Ventures for Up to $965M -- Update

13 oct. 2025, 21:06 UTC

Acquisitions, Fusions, Rachats

Goldman Buys $7B Venture-Capital Firm in Latest Asset-Management Bet -- Barrons.com

13 oct. 2025, 20:52 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs to Acquire Industry Ventures for Up to $965M

13 oct. 2025, 20:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

13 oct. 2025, 20:35 UTC

Acquisitions, Fusions, Rachats

Goldman Expects to Close Deal in 1Q

13 oct. 2025, 20:34 UTC

Acquisitions, Fusions, Rachats

Industry Ventures Will Be Part of Goldman's External Manager Platform, External Investing Group

13 oct. 2025, 20:33 UTC

Acquisitions, Fusions, Rachats

Industry Ventures Currently Manages $7B of Assets Under Supervision

13 oct. 2025, 20:32 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs: Deal to Include Up to $300M of Additional Contingent Consideration Based on Future Performance Through 2030

13 oct. 2025, 20:31 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs: Consideration to Include $665M Cash and Equity Payable at Closing

13 oct. 2025, 20:29 UTC

Acquisitions, Fusions, Rachats

Goldman Sachs to Buy VC Firm Industry Ventures

13 oct. 2025, 19:05 UTC

Market Talk

Oil Futures Pick Up on Easing U.S.-China Tension -- Market Talk

13 oct. 2025, 18:59 UTC

Market Talk

U.S. Natural Gas Futures Snap Losing Streak -- Market Talk

13 oct. 2025, 18:26 UTC

Market Talk

Precious Metals Close at New Record Highs -- Market Talk

13 oct. 2025, 18:10 UTC

Market Talk

Global Equities Roundup: Market Talk

13 oct. 2025, 18:10 UTC

Market Talk

Broadcom's OpenAI Deal Highlights AI Opportunity -- Market Talk

13 oct. 2025, 17:05 UTC

Market Talk

Global Equities Roundup: Market Talk

13 oct. 2025, 17:05 UTC

Market Talk

OpenAI Deal Offers Huge Upside to Broadcom's Earnings -- Market Talk

13 oct. 2025, 16:03 UTC

Acquisitions, Fusions, Rachats

Umicore Completes Sale, Subsequent Lease-in of Permanent Gold Inventories

13 oct. 2025, 15:35 UTC

Market Talk

Precious Metals Push Record Highs Further -- Market Talk

Comparaison

Variation de prix

Vivani Medical prévision

Objectif de Prix

By TipRanks

191.97% hausse

Prévisions sur 12 Mois

Moyen 4 USD  191.97%

Haut 4 USD

Bas 4 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat

2 ratings

2

Achat

0

Maintien

0

Vente

Éléments financiers

$

À Propos Vivani Medical

Vivani Medical, Inc., a preclinical stage biopharmaceutical company, engages in the development of miniaturized and subdermal implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease, medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in preclinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature, subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant is under development for metabolic diseases in cats including for the treatment of obesity and diabetes. The company is headquartered in Alameda, California.
help-icon Live chat